高级检索
当前位置: 首页 > 详情页

Deletion of FOXL2 by CRISPR promotes cell cycle G0/G1 restriction in KGN cells

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

单位: [1]Department of International Medicine, China Japan Friendship Hospital, Beijing 100029 [2]Shandong Provincial Key Laboratory of Plastic and Microscopic Repair Technology, Institute of Plastic Surgery, Weifang Medical University, Weifang, Shandong 461042 [3]Beijing Ruijian Technology Co., Ltd., Beijing 100086, P.R. China
出处:
ISSN:

关键词: forkhead box L2 clustered regularly interspaced short palindromic repeats ovarian granulosa cell cell cycle

摘要:
Forkhead box L2 (FOXL2), a member of the forkhead family of transcription factors, is important in eyelid and ovary differentiation. Although the function of FOXL2 in organogenesis has been investigated, the detailed mechanisms by which FOXL2 mediates cellular process remain to be fully elucidated. Few FOXL2-knockout cell lines have been reported, which has limited molecular mechanism investigations. CRISPR is a novel gene editing technique that has been widely used in human genetic diseases. In the present study, FOXL2 was disrupted using clustered regularly interspaced short palindromic repeats (CRISPR), and screening of a stable knockout cell line was performed in human ovarian granulosa KGN cells. Three sites (F404, F425 and F446) around the ATG start codon on the FOXL2 DNA sequence were constructed in a guide RNA lentivirus. Targeting F425 was most efficient, and western blot analysis and DNA sequencing of the resulting cells suggested that both FOXL2 alleles were fully disrupted. In addition, flow cytometry results indicated that the knockout of FOXL2 restricted cell cycle progression at the G0/G1 phase. In addition, the expression levels of cell cycle mediators cyclin D1 and cyclin-dependent kinase 4 were reduced. These results confirmed that FOXL2 disruption in KGN cells is associated with the cell cycle attenuation.

基金:
语种:
被引次数:
WOS:
中科院(CAS)分区:
出版当年[2018]版:
大类 | 3 区 医学
小类 | 4 区 医学:研究与实验
最新[2025]版:
大类 | 2 区 医学
小类 | 2 区 医学:研究与实验
JCR分区:
出版当年[2017]版:
Q2 MEDICINE, RESEARCH & EXPERIMENTAL
最新[2024]版:
Q1 MEDICINE, RESEARCH & EXPERIMENTAL

影响因子: 最新[2024版] 最新五年平均[2021-2025] 出版当年[2017版] 出版当年五年平均[2013-2017] 出版前一年[2016版] 出版后一年[2018版]

第一作者:
第一作者单位: [1]Department of International Medicine, China Japan Friendship Hospital, Beijing 100029
通讯作者:
通讯机构: [1]Department of International Medicine, China Japan Friendship Hospital, Beijing 100029 [3]Beijing Ruijian Technology Co., Ltd., Beijing 100086, P.R. China [*1]Department of International Medicine, China Japan Friendship Hospital, 2 Yinghuayuan East Street, Chaoyang, Beijing 100029, P.R. China [*2]Beijing Ruijian Technology Co., Ltd., 113, Zhichun Road, Haidian, Beijing 100086, P.R. China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:1320 今日访问量:0 总访问量:819 更新日期:2025-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)